Sylvie Colin
15Patents
3h-index
10Co-inventors
53Inventor score
Filing activity: Sep 3, 2004 → Jan 17, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9682144B2 | Composition comprising inhibitors of IRS-1 and of VEGF | Chemistry; Metallurgy | 4 | Active |
| US7553492B2 | Pharmaceutical compositions containing angiogenic activators | Chemistry; Metallurgy | 4 | Expired |
| US7993665B2 | Wound healing agent and composition | Human Necessities | 4 | Active |
| US8133877B2 | Composition comprising an antisense sequence implicated in the regulation of angiogenesis | Chemistry; Metallurgy | 3 | Active |
| US9539306B2 | Anti-tumor drug, medicament, composition, and use thereof | Chemistry; Metallurgy | 3 | Active |
| US7674770B2 | Anti-tumor drug, medicament, composition, and use thereof | Chemistry; Metallurgy | 2 | Active |
| US8742067B2 | Anti-tumor drug, medicament, composition, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US9359604B2 | Inhibitor of IRS-1 for treating skin disorders | Chemistry; Metallurgy | 0 | Active |
| US8188044B2 | Anti-tumor drug, medicament, composition, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US8372810B2 | Anti-tumor drug, medicament, composition, and use thereof | Human Necessities | 0 | Active |
| US9206236B2 | Peptides for treating cancer | Human Necessities | 0 | Active |
| US8288334B2 | Peptides for wound healing | Human Necessities | 0 | Active |
| US7906621B2 | Anti-tumor drug, medicament, composition, and use thereof | Human Necessities | 0 | Active |
| US7803906B2 | Composition comprising an angiogenesis related protein | Human Necessities | 0 | Expired |
| US8383591B2 | Peptides for treating cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.